AMINOCAPROIC ACID
AMINOCAPROIC ACID · HYPERFIBRINOLYSIS-INDUCED HEMORRHAGE ·+1
Hospira
Drug class
Antifibrinolytics
Antifibrinolytics are a therapeutic class of hemostatic agents that prevent the breakdown of blood clots by inhibiting the enzymatic dissolution of fibrin. Read more about Antifibrinolytics
63 drugs in this class 56 manufacturers
Drugs in Antifibrinolytics
TRANEXAMIC ACID
ANTIFIBRINOLYTICS · HEMORRHAGING IN HEMOPHILIA ·+1
ATHENEX PHARMAC
TRANEXAMIC ACID
ANTIFIBRINOLYTICS · HEMORRHAGING IN HEMOPHILIA ·+1
ALVOGEN INC
TRANEXAMIC ACID
ANTIFIBRINOLYTICS · MENORRHAGIA
Actavis Pharma
FIBRYGA (fibrinogen)
ANTIFIBRINOLYTICS · AFIBRINOGENEMIA ·+1
OCTAPHARMA USA
AMINOCAPROIC ACID
AMINOCAPROIC ACID · HYPERFIBRINOLYSIS-INDUCED HEMORRHAGE ·+1
VITRUVIAS THERA
AMINOCAPROIC ACID
AMINOCAPROIC ACID · HYPERFIBRINOLYSIS-INDUCED HEMORRHAGE ·+1
Amneal Pharmaceuticals
AMINOCAPROIC ACID
AMINOCAPROIC ACID · HYPERFIBRINOLYSIS-INDUCED HEMORRHAGE ·+1
AMERICAN REGENT
TRANEXAMIC ACID
ANTIFIBRINOLYTICS · HEMORRHAGING IN HEMOPHILIA ·+1
METHAPHARM INC
Filter & compare in the drug finder →
Opens the drug finder with Antifibrinolytics preselected. Add indication or manufacturer filters there.
Antifibrinolytics are a therapeutic class of hemostatic agents that prevent the breakdown of blood clots by inhibiting the enzymatic dissolution of fibrin.
Primarily comprising synthetic lysine analogues such as tranexamic acid and aminocaproic acid, these medications bind to lysine receptor sites on plasminogen and plasmin, thereby preventing plasmin from binding to and degrading the fibrin meshwork.
By stabilizing hemostatic clots and reducing blood loss, antifibrinolytics are widely utilized in major surgical procedures, traumatic hemorrhage, heavy menstrual bleeding, postpartum hemorrhage, and perioperative management for patients with congenital or acquired bleeding disorders.
-
fda.gov
Antifibrinolytics are a therapeutic class of hemostatic agents that prevent the breakdown of blood clots by inhibiting the enzymatic dissolution of fibrin Primarily comprising synthetic lysine analogues such as tranexamic acid and aminocaproic acid, these medications bind to lysine receptor sites on plasminogen and plasmin, thereby preventing plasmin from binding to and degrading the fibrin meshwork
-
nih.gov
Antifibrinolytics are a therapeutic class of hemostatic agents that prevent the breakdown of blood clots by inhibiting the enzymatic dissolution of fibrin Primarily comprising synthetic lysine analogues such as tranexamic acid and aminocaproic acid, these medications bind to lysine receptor sites on plasminogen and plasmin, thereby preventing plasmin from binding to and degrading the fibrin meshwork By stabilizing hemostatic clots and reducing blood loss, antifibrinolytics are widely utilized in...
-
fda.gov
Primarily comprising synthetic lysine analogues such as tranexamic acid and aminocaproic acid, these medications bind to lysine receptor sites on plasminogen and plasmin, thereby preventing plasmin from binding to and degrading the fibrin meshwork By stabilizing hemostatic clots and reducing blood loss, antifibrinolytics are widely utilized in major surgical procedures, traumatic hemorrhage, heavy menstrual bleeding, postpartum hemorrhage, and perioperative management for patients with congenita...
-
nih.gov
By stabilizing hemostatic clots and reducing blood loss, antifibrinolytics are widely utilized in major surgical procedures, traumatic hemorrhage, heavy menstrual bleeding, postpartum hemorrhage, and perioperative management for patients with congenital or acquired bleeding disorders
-
nih.gov
By stabilizing hemostatic clots and reducing blood loss, antifibrinolytics are widely utilized in major surgical procedures, traumatic hemorrhage, heavy menstrual bleeding, postpartum hemorrhage, and perioperative management for patients with congenital or acquired bleeding disorders
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.